Latest Tax Refunds News

Barton Gold Holdings has raised $3 million through a premium-priced placement to fast-track resource upgrade drilling at its Tunkillia Gold Project, boosting its cash reserves to $9 million with minimal dilution.

Health and Plant Protein Group Ltd (HPP) has received a US$3.38 million tax refund from the US IRS linked to its 2023 US subsidiary sale, slightly exceeding prior estimates. The company plans to return surplus assets to shareholders and pursue strategic growth opportunities under a leaner cost structure.

Anatara Lifesciences has obtained a $400,000 loan advance from a major shareholder group against its estimated R&D tax refund for the first half of FY2025, providing crucial funding to support ongoing clinical trials and product development without immediate capital raising.

Omega Oil and Gas has reported robust oil and gas flows from its Canyon-1H well in Queensland’s Bowen Basin, confirming commercial potential and securing $7 million in fresh capital alongside a strategic board appointment.

AXP Energy has completed a successful 60-day gas-to-power trial at its Pathfinder Field, delivering 1.5 MW of off-grid power and generating maiden natural gas revenue. The company is accelerating its expansion plans, backed by NASDAQ-listed BitFuFu, aiming to scale operations to 25 MW by year-end.

Evolution Energy Minerals initiates a strategic review and cost-cutting at its Chilalo graphite project while progressing a farm-out deal for its Chikundu Cu-Pb-Zn VHMS prospect with Oscillate plc.

Patrys Limited advances its PAT-DX3 therapy development for inflammatory diseases while navigating cash flow challenges and pursuing partnerships to sustain operations.

Red Metal Limited's March 2025 quarterly report reveals robust progress across its rare earth and base metals projects, underpinned by promising drilling results and supportive government funding.

Barton Gold Holdings reported a 120,000-ounce gold resource increase at Tunkillia and uncovered exceptional high-grade silver at Tarcoola’s Tolmer prospect, alongside a $3.1 million half-year profit and accelerated feasibility studies.

Optiscan Imaging Ltd has revealed its next-generation InForm™ pathology imaging device and strengthened its executive team, while reporting a robust cash position supported by a $1.775 million R&D tax refund for the quarter ended 31 March 2025.

Imugene Limited reports encouraging Phase 1b results for azer-cel in lymphoma, secures FDA Fast Track status, and strengthens patent portfolio while raising A$20 million to fuel ongoing immuno-oncology programs.

VHM Limited has achieved a key milestone with mining licence approval for its Goschen Rare Earths and Mineral Sands Project, alongside a revised staged expansion plan that adjusts capital and operating costs while extending Major Project Status.